Stock RASP ACTAVIA LIFE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Actavia Life Sciences, Inc.

Equities

RASP

US7538881068

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 12:28:19 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0173 USD +121.79% Intraday chart for Actavia Life Sciences, Inc. +121.79% +124.68%
Feb. 16 Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Jan. 05 Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI

Business Summary

Actavia Life Sciences, Inc. is a leukemia-focused biotechnology company. The Company is engaged in developing therapeutics to address the unmet need that exists for acute myeloid leukemia (AML), and other forms of leukemia and lymphoma. AML is generally a disease of older adults. It develops small molecule drug candidates targeting the LSD1 gene, which controls pathways underlying the etiology of AML subtypes. Its RASP-201 is a novel, orally dosed, selective reversible inhibitor of lysine specific demethylase (LSD1), a pathway that blocks differentiation and confers a poor prognosis to AML. RASP-201 when dosed orally shows in vivo therapeutic utility in murine (mouse) models of AML. Its primary indication is AML which may be fatal within weeks to months.

Number of employees: 1

Managers

Managers TitleAgeSince
Keeren Shah DFI
 Director of Finance/CFO 47 16-06-30
Jules S. Jacob PRN
 Corporate Officer/Principal - 17-06-30

Members of the board

Members of the board TitleAgeSince
John Brancaccio BRD
 Director/Board Member 76 16-07-31
Willy Simon CHM
 Chairman 72 20-10-13
Gary Jacob BRD
 Director/Board Member 77 20-12-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 771,811,360 114,303,692 ( 14.81 %) 0 14.81 %

Shareholders

NameEquities%Valuation
Panetta Partners Ltd.
85.26 %
658,036,668 85.26 % 9 M $
John Brancaccio
0.000000 %
0 0.000000 % - $
Gary Jacob
0.000000 %
0 0.000000 % - $

Company contact information

Actavia Life Sciences, Inc.

5 Penn Plaza Suite 1954

10001, New York

+

http://www.rasna.com
address Actavia Life Sciences, Inc.(RASP)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ACTAVIA LIFE SCIENCES, INC. Stock Actavia Life Sciences, Inc.
+124.68% 13.35M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.43% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+8.96% 101B
ARGENX SE Stock argenx SE
+4.40% 23.07B
BIONTECH SE Stock BioNTech SE
-12.15% 22.23B
GENMAB A/S Stock Genmab A/S
-4.36% 18.05B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.04% 16.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.79% 14.07B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+38.61% 12.35B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. RASP Stock
  4. Company Actavia Life Sciences, Inc.